Evidence of endothelial progenitor cells in the human brain and spinal cord arteriovenous malformations

Neurosurgery

Volumn 67, Issue 4, 2010, Pages 1029-1035

  Gao, Peng ^a,b   Chen, Yongmei ^a   Lawton, Michael T ^a   Barbaro, Nicholas M ^a   Yang, Guo Yuan ^a,c   Su, Hua ^a   Ling, Feng ^b   Young, William L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Endothelial progenitor cell; Stromal cell derived factor 1; Vascular malformation

Indexed keywords

CD133 ANTIGEN; CD31 ANTIGEN; CD68 ANTIGEN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTERIOVENOUS MALFORMATION; ARTICLE; BASILAR ARTERY; BLOOD VESSEL WALL; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN CORTEX; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIAL PROGENITOR CELL; EPILEPSY; HEMANGIOBLASTOMA; HUMAN; HUMAN TISSUE; MENINGIOMA; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SPINAL CORD ARTERIOVENOUS MALFORMATION; SPINAL CORD DISEASE; STEM CELL;

ANTIGENS, CD; ARTERIOVENOUS MALFORMATIONS; BRAIN; CHEMOKINE CXCL12; ENDOTHELIAL CELLS; ENDOTHELIUM; GLYCOPROTEINS; HUMANS; MICROSURGERY; PEPTIDES; SPINAL CORD; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77958003487     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e3181ecc49e     Document Type: Article

References (52)

1. Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PMcL. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery. 2000;46(5):1179-1191. (Pubitemid 30249949)
2. Hashimoto T, Wu Y, Lawton MT, Yang GY, Barbaro NM, Young WL. Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery. 2005;56(5):1058-1065. (Pubitemid 40628114)
3. Hashimoto T, Wen G, Lawton MT, et al. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke. 2003;34(4):925-931. (Pubitemid 36402962)
4. Koizumi T, Shiraishi T, Hagihara N, Tabuchi K, Hayashi T, Kawano T. Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery. 2002;50(1):117-124. (Pubitemid 41672561)
5. Chen Y, Fan Y, Poon KY, et al. MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci. 2006;11:3121-3128. (Pubitemid 43800401)
6. Kawamoto A, Losordo DW. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med. 2008;18(1):33-37.
7. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95(4):343-353. (Pubitemid 39100452)
8. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001;7(11):1194-1201. (Pubitemid 33063774)
9. Rafii S, Lyden D. Cancer. A few to flip the angiogenic switch. Science. 2008;319(5860):163-164.
10. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science. 2008;319(5860):195-198.
11. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7):593-600. (Pubitemid 36204953)
12. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353(10):999-1007. (Pubitemid 41262334)
13. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283(5403):845-848. (Pubitemid 129501124)
14. Halim AX, Singh V, Johnston SC, et al. Characteristics of brain arteriovenous malformations with coexisting aneurysms: a comparison of two referral centers. Stroke. 2002;33(3):675-679. (Pubitemid 34203988)
15. Hashimoto T, Lawton MT, Wen G, et al. Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery. 2004;54(2):410-423. (Pubitemid 38209411)
16. Bajetto A, Barbieri F, Pattarozzi A, et al. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Neuro Oncol. 2007;9(1):3-11. (Pubitemid 46543483)
17. Hu W, Shen F, Chen G, Shen G, Liu W, Zhou J. Possible involvement of brain tumour stem cells in the emergence of a fast-growing malignant meningioma after surgical resection and radiotherapy of high-grade astrocytoma: case report and preliminary laboratory investigation. J Int Med Res. 2009;37(1):240-246.
18. Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet. 2002;359(9309):863-873.
19. Hashimoto T, Mesa-Tejada R, Quick CM, et al. Evidence of increased endothelial cell turnover in brain arteriovenous malformations. Neurosurgery. 2001;49(1): 124-131. (Pubitemid 32552590)
20. Hashimoto T, Emala CW, Joshi S, et al. Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery. 2000;47(4):910-918. (Pubitemid 32103667)
21. Chen Y, Pawlikowska L, Yao JS, et al. Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol. 2006;59(1):72-80. (Pubitemid 43042873)
22. Hatva E, Jääskeläinen J, Hirvonen H, Alitalo K, Haltia M. Tie endothelial cellspecific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations. J Neuropathol Exp Neurol. 1996;55(11):1124-1133. (Pubitemid 26372789)
23. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275(5302):964-967. (Pubitemid 27087709)
24. Miraglia S, Godfrey W, Yin AH, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. 1997;90(12):5013-5021. (Pubitemid 28007218)
25. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol. 2001;115(1):186-194. (Pubitemid 32995115)
26. Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med. 2005; 5679-6101 (Pubitemid 40299775)
27. Rouhl RP, van Oostenbrugge RJ, Damoiseaux J, Cohen Tervaert JW, Lodder J. Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke. 2008;39(7):2158-2165.
28. Diller GP, van Eijl S, Okonko DO, et al. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation. 2008;117(23):3020-3030.
29. Florek M, Haase M, Marzesco AM, et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res. 2005;319(1):15-26. (Pubitemid 40104635)
30. Corbeil D, Joester A, Fargeas CA, et al. Expression of distinct splice variants of the stem cell marker prominin-1 (CD133) in glial cells. Glia. 2009;57(8):860-874.
31. Asahara T, Kalka C, Isner JM. Stem cell therapy and gene transfer for regeneration. Gene Ther. 2000;7(6):451-457. (Pubitemid 30156558)
32. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):E1-E7.
33. Liew A, Barry F, O'Brien T. Endothelial progenitor cells: diagnostic and therapeutic considerations. Bioessays. 2006;28(3):261-270.
34. Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106(22):2781-2786.
35. Krankel N, Adams V, Linke A, et al. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol. 2005;25(4):698-703. (Pubitemid 40463856)
36. Dome B, Timar J, Dobos J, et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res. 2006;66(14):7341-7347. (Pubitemid 44197717)
37. Rigolin GM, Mauro E, Ciccone M, et al. Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. Eur J Haematol. 2007;78(5): 365-373. (Pubitemid 46558201)
38. Shirakawa K, Shibuya M, Heike Y, et al. Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. Int J Cancer. 2002;99(3):344-351. (Pubitemid 34495848)
39. Yu Y, Flint AF, Mulliken JB, Wu JK, Bischoff J Endothelial progenitor cells in infantile hemangioma. Blood. 2004;103(4):1373-1375. (Pubitemid 38168651)
40. Kleinman ME, Greives MR, Churgin SS, et al. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol. 2007;27(12):2664-2670.
41. Yodoi Y, Sasahara M, Kameda T, Yoshimura N, Otani A. Circulating hematopoietic stem cells in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48(12):5464-5472. (Pubitemid 351260846)
42. Sheridan CM, Rice D, Hiscott PS, Wong D, Kent DL. The presence of AC133- positive cells suggests a possible role of endothelial progenitor cells in the formation of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2006;47(4):1642-1645. (Pubitemid 46780777)
43. Taguchi A, Matsuyama T, Moriwaki H, et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation. 2004;109(24):2972-2975. (Pubitemid 38808318)
44. Ghani U, Shuaib A, Nasir A, et al. Endothelial progenitor cells during cerebrovascular disease. Stroke. 2005;36(1):151-153. (Pubitemid 40054193)
45. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18(14):3964-3972. (Pubitemid 29335849)
46. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10(8):858-864.
47. Yamaguchi J, Kusano KF, Masuo O, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107(9):1322-1328. (Pubitemid 36314418)
48. Pablos JL, Amara A, Bouloc A, et al. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am J Pathol. 1999;155(5): 1577-1586.
49. Nanki T, Hayashida K, El-Gabalawy HS, et al. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol. 2000;165(11):6590-6598.
50. Krumbholz M, Theil D, Cepok S, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain. 2006;129(pt 1):200-211. (Pubitemid 43063771)
51. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007;28(7):299-307. (Pubitemid 46963141)
52. Shenkar R, Elliott JP, Diener K, et al. Differential gene expression in human cerebrovascular malformations. Neurosurgery. 2003;52(2):465-478. (Pubitemid 36159440)